Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing

This article was originally published in The Tan Sheet

Executive Summary

FDA will wield tight oversight of Johnson & Johnson subsidiary McNeil Consumer Healthcare's OTC manufacturing operations under a consent decree filed after the firm's quality-control changes failed to satisfy the agency.
Advertisement

Related Content

Issa Scolds FDA On Failure To Inspect McNeil Plant
J&J Plans To Upgrade Recalled OTCs for Relaunch
Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012
Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012
Perrigo Takes Two Steps Forward: Generic Allegra Launch, Manufacturing Compliance
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
In Brief
Unit Sales Of Top 10 Largest OTC Categories In 2010
Pfizer's OTC, Nutritional Businesses Could Be Looking For A New Home
McNeil OTC Recalls Slice $900M From J&J's 2010 Sales

Topics

Advertisement
UsernamePublicRestriction

Register

PS104916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel